Second-line cabozantinib after sorafenib treatment for advanced hepatocellular carcinoma: a subgroup analysis of the phase 3 CELESTIAL trial
- Issued Date
- 2020
- Type
- Article
- Publisher
- Esmo Open
- Language
- 영어
- ISSN
- 2059-7029
- Citation Volume
- 5
- Citation Number
- 4
- Citation Start Page
- 000714
- Citation End Page
- 000714
- 파일 목록
-
-
관련 파일이 존재하지 않습니다.
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.